Immunome Inc. IMNM
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Immunome Inc. is a biotechnology company specializing in highly innovative research and development within the life sciences sector. The primary focus of the company is to advance immunotherapy-based cancer treatments through its proprietary discovery engine that harnesses the immune system's natural capabilities. Immu…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees206
TickerIMNM
Statistics
Market Cap$2.08B
Revenue (TTM)$6.9M
Net Income-$212.4M
Net Margin-3060.0%
EPS$-2.43
P/E-7.57
P/S512.24
P/B3.49
EV/EBITDA-6.53
ROE-50.1%
Dividend Yield—
Price$18.34
Data: Twelve Data · Revenue = mcap / P/S